Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Dopamine Receptor

Dopamine receptors (DR) are members of G protein-coupled receptors superfamily. There are 5 subtypes (D1, D2, D3, D4, D5) of DR which mediate the functions of dopamine in central nervous system for control of locomotion, cognition, and emotion etc.

Items 1-10 of 97

Page
per page
  1. Levodopa
    A8460 Levodopa
    Summary: Dopamine precursor.
      insoluble in DMSO; insoluble in EtOH; ≥6.57 mg/mL
  2. Paliperidone
    A8496 Paliperidone
    Target: 5-HT2 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|Histamine H1 Receptors
    Summary: Dopamine receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥10.662 mg/mL
  3. Chlorprothixene
    A8398 Chlorprothixene
    Summary: Dopamine receptor antagonist
      insoluble in H2O; ≥13.43 mg/mL
  4. Vanoxerine dihydrochloride
    B3248 Vanoxerine dihydrochloride
     1 Citation
    Summary: potent and selective DRI (Dopamine reuptake inhibitor)
      insoluble in EtOH; ≥15.4 mg/mL
  5. Vanoxerine
    B3249 Vanoxerine
    Summary: potent and selective DRI (Dopamine reuptake inhibitor)
      Soluble in DMSO
  6. Sitaxentan sodium
    B1522 Sitaxentan sodium
    Summary: Selective endothelin A receptor (ETA) antagonist
      ≥23.84 mg/mL
  7. Ambrisentan
    B2075 Ambrisentan
    Target: ETA Receptors
    Summary: ETA-receptor antagonist
      insoluble in H2O; ≥18.92 mg/mL
  8. Fenoldopam (mesylate)
    B8681 Fenoldopam (mesylate)
      insoluble in EtOH; ≥10.8 mg/mL
  9. Fluphenazine dihydrochloride
    B6132 Fluphenazine dihydrochloride
    Summary: phenothiazine-class D1DR and D2DR inhibitor
      ≥114.2 mg/mL
  10. Perphenazine
    B6157 Perphenazine
    Summary: A dopamine antagonist

Items 1-10 of 97

Page
per page